Chris Jones is a patent agent and technical specialist at KramerAmado. He has a master’s degree in chemistry and a background in both chemical and biochemical technologies. Chris is currently pursuing his juris doctorate degree at George Mason University’s Antonin Scalia Law School and will graduate in December 2018.
Latest from Chris Jones
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023